ProAssurance (PRA) Up 0.8% Since Last Earnings Report: Can It Continue?

ProAssurance (PRA) shares have risen 0.8% since its last earnings report, underperforming the S&P 500, with analysts remaining quiet on earnings estimate revisions over the past two months. The stock has a Zacks Rank #4 (Sell), indicating an expected below-average return in the coming months, while competitor Axis Capital (AXS) has gained 4.3% over the past month and reported an 8.3% year-over-year revenue increase to $1.55 billion with EPS of $3.17.

Analysis

ProAssurance (PRA) has exhibited lackluster performance following its latest earnings report, with shares gaining a mere 0.8%, thereby underperforming the S&P 500. Notably, there have been no analyst earnings estimate revisions for PRA in the past two months, signaling a potential lack of fresh catalysts or conviction. The company's valuation and growth metrics appear unfavorable, as indicated by its poor VGM Scores: an 'F' for Growth, a 'D' for Value (placing it in the bottom 40% for this strategy), and an overall aggregate VGM Score of 'F'. Consistent with these weak indicators, ProAssurance holds a Zacks Rank #4 (Sell), suggesting an expectation of below-average returns in the forthcoming months. In contrast, Axis Capital (AXS), a peer in the Zacks Insurance - Property and Casualty industry, has seen its shares rise 4.3% over the past month. AXS reported a year-over-year revenue increase of 8.3% to $1.55 billion and an EPS of $3.17 for its quarter ended March 2025, compared to $2.57 a year ago. However, for the current quarter, AXS's earnings are projected at $2.92 per share, a 0.3% decrease year-over-year, and its Zacks Consensus Estimate has declined by 0.9% in the last 30 days, resulting in a Zacks Rank #3 (Hold) and a VGM Score of 'B'.

Key Decisions for Investors

• Given ProAssurance's Zacks Rank #4 (Sell), poor overall VGM score of 'F', and recent share price underperformance, investors should exercise significant caution and may consider reducing exposure.
• The absence of analyst earnings estimate revisions for PRA post-earnings, combined with its 'F' Growth Score, suggests a need to closely monitor for any signs of fundamental improvement or new catalysts before considering investment.
• Investors should note PRA's relative weakness compared to industry peers like Axis Capital, which, despite a 'Hold' rating and a slight dip in forward EPS estimates, has demonstrated better recent stock performance and more favorable historical earnings growth.